{"id":4452,"date":"2026-10-12T08:33:29","date_gmt":"2026-10-12T08:33:29","guid":{"rendered":"https:\/\/nhdbio.com\/?p=4452"},"modified":"2026-10-12T08:33:29","modified_gmt":"2026-10-12T08:33:29","slug":"explication-de-lexpansion-de-capacite-des-peptides-corden","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/fr\/corden-peptide-capacity-expansion-explained\/","title":{"rendered":"Expansion de l'usine de peptides : pourquoi la production utilisable n'augmente pas imm\u00e9diatement"},"content":{"rendered":"
\n
\"Themed
Editorial illustration, not an experimental photograph.<\/figcaption><\/figure>\n

Construction starting on a new plant sounds like more products will be available right away. CordenPharma's recent expansion update shows there is still a distance between the two: building completion, process operation and stable supply each need to be achieved separately.<\/p>\n

\n

What actual changes did this announcement bring?<\/h2>\n

In the company update on September 28, after acquiring AmbioPharm, the capabilities in North Augusta and Shanghai joined its network, and more than 400 employees joined. A groundbreaking ceremony was held for the new expansion project in North Augusta, which is planned to begin operation in early 2028.<\/p>\n

The locations, scale and timing here all belong to CordenPharma's project; they are not NHD's plant, and cannot be used to infer NHD's existing inventory.<\/p>\n<\/section>\n

\n

Synthesis capacity: why does a larger area not mean more output?<\/h2>\n

Peptides usually go through synthesis, cleavage, purification, separation and testing. Being able to handle more material at one step does not mean every later step can keep up.[1]<\/a><\/p>\n

It is like adding more stoves to a kitchen: washing, plating and serving can still become bottlenecks. To judge capacity, look at the whole process, not just one reaction vessel or one new building.<\/p>\n